Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Sun Pharma, Zydus sign licensing pact to co-market Desidustat for CKD treatment in India
The drug will be marketed by Sun Pharma under the brand name RYTSTAT. Zydus continues to market the drug under the brand name…
SPARC completes enrolment in PROSEEK, Phase 2 study of Vodobatinib in early Parkinson’s disease
506 patients completed enrolment across 84 sites in the US, Europe and India
SETU secures funding from HNIs
SETU aims to grow their business 30 times over the next five years, capitalising on strong category and channel growth
Monoclonal antibodies for Nipah treatment to be developed indigenously: Kerala Health Minister
The minister said the monoclonal antibodies were presently being imported from Australia where they are made according to the…
Venus Remedies gets market authorisation for Bleomycin 15,000 IU in the UK
Venus Remedies holds a total of 15 MA for Bleomycin products across the globe
DCGI approves KEYTRUDA to treat triple negative breast cancer, renal cell carcinoma
KEYTRUDA is now approved for 14 indications across eight tumour types in India
Dr Reddy’s launches D2C e-commerce website ‘Celevida Wellness’ for diabetes
Launch enables the company to reach more consumers, strengthens play in nutraceuticals which started in 2019 through its flagship…
IIT Mandi, DBT-inStem researchers discover biochemistry behind resilience of dengue mosquito eggs
This research lays the foundation for innovative mosquito control methods, potentially reducing disease transmission
WHO trivalent recommendations will reshape global flu vaccine market: GlobalData
WHO recently advised a reversion to trivalent (three-strain) influenza vaccines for the 2024 southern hemisphere influenza…
Zydus begins Phase II trial of ZYIL1, NLRP3 inhibitor in patients with ALS
USFDA has granted Zydus an ‘Orphan Drug Designation’ for ZYIL1 to treat patients with Cryopyrin Associated Periodic Syndrome…